🇺🇸 Semaglutide Pill in United States

FDA authorised Semaglutide Pill on 16 January 2020

Marketing authorisations

FDA — authorised 16 January 2020

  • Application: NDA213182
  • Marketing authorisation holder: NOVO NORDISK INC
  • Local brand name: RYBELSUS
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

Semaglutide Pill in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Semaglutide Pill approved in United States?

Yes. FDA authorised it on 16 January 2020; FDA has authorised it.

Who is the marketing authorisation holder for Semaglutide Pill in United States?

NOVO NORDISK INC holds the US marketing authorisation.